| P50 | author | Maria Violetta Brundo | Q42760737 |
| | Calogero Vetro | Q43188841 |
| | Alessandra Romano | Q57207329 |
| | Cesarina Giallongo | Q58806464 |
| | Salvatore Antonino Raccuia | Q59661143 |
| | Daniele Tibullo | Q61116197 |
| | Fabrizio Puglisi | Q97687448 |
| | Nunziatina L Parrinello | Q114404103 |
| | Piera La Cava | Q114404104 |
| P2093 | author name string | Francesco Coppolino | |
| | Flavia Ancora | |
| P2860 | cites work | Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 |
| | Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 |
| | Coordinated regulation of myeloid cells by tumours | Q28395157 |
| | Subsets of myeloid-derived suppressor cells in tumor-bearing mice | Q29614297 |
| | Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma | Q30431530 |
| | Modulators of arginine metabolism support cancer immunosurveillance | Q33398779 |
| | Immunological deregulation in classic hodgkin lymphoma. | Q33778391 |
| | Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells | Q33919954 |
| | Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | Q33962334 |
| | Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment | Q34628392 |
| | Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. | Q35195777 |
| | The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 |
| | Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma | Q35902813 |
| | Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer | Q36260673 |
| | Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial | Q36333526 |
| | Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy | Q37100179 |
| | Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. | Q37118160 |
| | Th17 and Treg cells in bone related diseases | Q37239790 |
| | The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression | Q37253328 |
| | Regulatory myeloid suppressor cells in health and disease | Q37373257 |
| | Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. | Q37378324 |
| | Tumor-associated macrophages: effectors of angiogenesis and tumor progression. | Q37408808 |
| | Cellular and molecular pathways linking inflammation and cancer | Q37555395 |
| | Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome | Q37659012 |
| | The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. | Q37763027 |
| | An overview of chronic lymphocytic leukaemia biology | Q37771663 |
| | Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy | Q37863217 |
| | Macrophages in multiple myeloma | Q38173982 |
| | Immunological dysregulation in multiple myeloma microenvironment. | Q38228353 |
| | Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. | Q39244686 |
| | A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma | Q39483693 |
| | Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis? | Q41474606 |
| | Dysfunctional T regulatory cells in multiple myeloma | Q41877240 |
| | Macrophages predict treatment outcome in Hodgkin's lymphoma | Q42586761 |
| | Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma | Q42591459 |
| | Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma | Q43683700 |
| | Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses | Q45020410 |
| | Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells | Q45299110 |
| | High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. | Q46845329 |
| | Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells | Q47600079 |
| | Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state | Q47985426 |
| | Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. | Q51037023 |
| | In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. | Q51985543 |
| | Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells | Q57279527 |
| | Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma | Q59245171 |
| | Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma | Q79615488 |
| | Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia | Q80152381 |
| | Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma | Q80556384 |
| | Advances in understanding regulatory myeloid cells | Q83809916 |
| | Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma | Q84001585 |
| | Increased numbers of T helper 17 cells and the correlation with clinicopathological characteristics in multiple myeloma | Q84185853 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 104 | |
| P577 | publication date | 2015-05-21 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells | |
| P478 | volume | 5 | |